4//SEC Filing
Schaffnit Jeffrey R. 4
Accession 0001209191-18-033891
CIK 0001659323other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 5:08 PM ET
Size
8.6 KB
Accession
0001209191-18-033891
Insider Transaction Report
Form 4
Schaffnit Jeffrey R.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-05-24+25,461→ 25,461 totalExercise: $13.00Exp: 2028-05-23→ Ordinary Shares (25,461 underlying) - Award
Stock Option (Right to Buy)
2018-05-24+6,365→ 6,365 totalExercise: $13.00Exp: 2028-05-23→ Ordinary Shares (6,365 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of February 19, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
- [F2]The shares subject to this option shall vest at a rate of twenty-five percent of the total number of shares on the one-year anniversary of May 24, 2018 (the "Vesting Commencement Date") and 1/48th of the total number of shares each monthly anniversary of the Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date.
Documents
Issuer
Iterum Therapeutics plc
CIK 0001659323
Entity typeother
Related Parties
1- filerCIK 0001734032
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 5:08 PM ET
- Size
- 8.6 KB